Pembrolizumab a Successful Adjuvant Treatment for High-Risk Melanoma
Recurrence-free survival in patients with melanoma treated with pembrolizumab are reported.
Melanoma
US Melanoma Incidence May Be Stabilizing for First Time in a Century
Data suggest the overall incidence of melanoma in the United States is stabilizing after nearly a century of continuous increase.
Opdualag Approved for Unresectable, Metastatic Melanoma
Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody.
Sunburn Diagnosis More Prevalent in Obese Individuals
The relationship between obesity and sunburn diagnosed during a medical examination is examined.
HLA Variant May Predict Poor Outcomes of Immunotherapy in Cancer Patients
HLA-A*03 was associated with worse progression-free and overall survival.
Many Oncology Drugs Approved for Genomic Indications Not Studied for Overall Survival Outcomes
Overall survival data were available for about half of the drugs.
How the University of Mississippi is Overcoming Gaps in Rural Dermatology Care
A presentation at the 2021 Summer Meeting of the AAD reviews the novel approaches taken by the University of Mississippi, Department of Dermatology to address gaps in rural care.
Model More Accurately Predicts Outcomes of Radiotherapy in Cancer Patients
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
Melanoma Brain Metastases: ‘Absolutely Treatable in 2021’
Experts outline treatment options and make recommendations.
COVID-19 Lockdown: Melanomas Still Diagnosed but Follow-Up Decreased
Italian researchers retrospectively compared dermatologic and surgical activity in their melanoma unit from February to May, 2020, with data from the same period in 2019.
- Loading...
Loading...
Loading... 
Loading...